Tenaya Therapeutics Inc (NASDAQ:TNYA) has a beta value of 2.34 and has seen 37.2 million shares traded in the last trading session. The company, currently valued at $192.10M, closed the last trade at $2.41 per share which meant it gained $0.47 on the day or 24.23% during that session. The TNYA stock price is -190.87% off its 52-week high price of $7.01 and 33.2% above the 52-week low of $1.61. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.45 million shares traded. The 3-month trading volume is 482.69K shares.
The consensus among analysts is that Tenaya Therapeutics Inc (TNYA) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information
Sporting 24.23% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TNYA stock price touched $2.41 or saw a rise of 12.36%. Year-to-date, Tenaya Therapeutics Inc shares have moved -25.62%, while the 5-day performance has seen it change 15.87%. Over the past 30 days, the shares of Tenaya Therapeutics Inc (NASDAQ:TNYA) have changed 36.16%. Short interest in the company has seen 4.88 million shares shorted with days to cover at 9.77.
Tenaya Therapeutics Inc (TNYA) estimates and forecasts
Figures show that Tenaya Therapeutics Inc shares have underperformed across the wider relevant industry. The company’s shares have lost -46.92% over the past 6 months, with this year growth rate of 9.52%, compared to 17.50% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -27.43% over the past 5 years.
TNYA Dividends
Tenaya Therapeutics Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Tenaya Therapeutics Inc (NASDAQ:TNYA)’s Major holders
Insiders own 1.18% of the company shares, while shares held by institutions stand at 73.75% with a share float percentage of 74.64%. Investors are also buoyed by the number of investors in a company, with Tenaya Therapeutics Inc having a total of 137.0 institutions that hold shares in the company. The top two institutional holders are COLUMN GROUP LLC with over 9.4 million shares worth more than $29.14 million. As of 2024-06-30, COLUMN GROUP LLC held 11.6078% of shares outstanding.
The other major institutional holder is RA CAPITAL MANAGEMENT, L.P., with the holding of over 7.62 million shares as of 2024-06-30. The firm’s total holdings are worth over $23.63 million and represent 9.4124% of shares outstanding.
